Dialogues in Cardiovascular Medicine - Vol 9 . No. 1 . 2004



Genetic Risk Factors & Cardiovascular Disease




The genetics of cardiovascular disease: from genotype to phenotype
R. Sanders Williams, P. J. Goldschmidt-Clermont




In what situations is genetic testing currently useful for management of individual patients to prevent or treat cardiovascular disease?
I. N. M. Day


In what manner are advances in genetics most likely to alter the clinical practice of cardiology within the next 10 years?
A. S. Hall


Should genetic testing become a standard component of clinical trials in order to advance evidence-based cardiology practice?
H. Watkins




Icons of Cardiology: Carl J. Wiggers and the foundation of modern cardiology
A. M. Katz




E. Blair


A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation
A. A. Geisterfer-Lowrance and others

Toll-like receptor 4 polymorphisms and atherogenesis
S. Kiechl and others

Prospects for whole-genome linkage disequilibrium mapping of common disease genes
L. Kruglyak

Genetic isolates: separate but equal?
L. Kruglyak

Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy
R. Coral-Vazquez and others
A calcineurin-dependent transcriptional pathway for cardiac hypertrophy
J. D. Molkentin and others

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
M. E. Curran and others

Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene
H. C. Dietz and others

Molecular medicine. The cholesterol quartet
J. L. Goldstein and M. S. Brown

Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo
B. A. Rothermel and others




© 2008 LES LABORATOIRES SERVIER, an incorporated company of SERVIER All Rights Reserved - Updates